Effect of liraglutide on physical performance in type 2 diabetes: Results of a randomized, double-blind, controlled trial (LIPER2)

Autor: Wägner, A.M., Miranda-Calderín, G., Ugarte-Lopetegui, M.A., Marrero-Santiago, H., Suárez-Castellano, L., López-Madrazo, M.J., Alberiche-Ruano, M.P., Abselam Ahmed, N., Alemán, C., Castellot-Martín, A., Díez del Pino, A., Nóvoa-Mogollón, F.J.

Publikováno v: In Diabetes & Metabolism June 2019 45(3):268-275

Effect of liraglutide on physical performance in type 2 diabetes (LIPER2): A randomised, double-blind, controlled trial

Autor: Ana María Wägner, Guillermo Miranda-Calderín, Miren Arantza Ugarte-Lopetegui, Héctor Marrero-Santiago, Laura Suárez-Castellano, María del Pino Alberiche-Ruano, Nuria Castillo-García, María José López-Madrazo, Carolina Alemán, Carla Martínez-Mancebo, Laura López-Ríos, Alicia Díez del Pino, Francisco Javier Nóvoa-Mogollón

Publikováno v: Contemporary Clinical Trials Communications, Vol 4, Iss C, Pp 46-51 (2016)

Preclinical studies and small clinical trials suggest that glucagon-like peptide 1 (GLP1) may have a positive effect on ventricular function. Liraglutide is a GLP1-analogue used in the treatment of type 2 diabetes. LIPER2 is a phase IV, randomised, d

Externí odkaz: https://doaj.org/article/3c0d1dfcf9bd4529a6d9e8cd73143ff6

Eficiencia de un protocolo de uso de palivizumab en pacientes prematuros

Autor: Yolanda, Hernández-Gago, Marina, Lombardero-Pin, Casilda, Ortega de la Cruz, Pablo A, Maciuniak, Alicia, Díez Del Pino

Publikováno v: Farmacia Hospitalaria, Vol 41, Iss 2, Pp 169-186 (2017)
Farmacia Hospitalaria v.41 n.2 2017
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname

The main objective was to evaluate the cost-effectiveness of protocol use of palivizumab in premature established by consensus in our Hospital comparing it based on the recommendations of various Scientific Societies. As a secondary objective risk fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::42b198900ca947ae878727491541b1f3
https://hdl.handle.net/10668/2668

Cost effectiveness of a protocol using palivizumab in preterm infants

Autor: Hernández-Gago, Yolanda, Lombardero-Pin, Marina, Ortega de la Cruz, Casilda, Maciuniak, Pablo A, Díez del Pino, Alicia

Publikováno v: Farmacia Hospitalaria, Volume: 41, Issue: 2, Pages: 169-186, Published: APR 2017

Objective: The main objective was to evaluate the cost-effectiveness of protocol use of palivizumab in premature established by consensus in our Hospital comparing it based on the recommendations of various Scientific Societies. As a secondary object

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______624::3f2ea522ed9b9b951d209410d2b2f716
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432017000200169&lng=en&tlng=en

Poliserositis en paciente con hepatitis C en tratamiento con los nuevos antivirales

Autor: Lombardero Pin, Marina, Otero Villalustre, Cristina, Nucete Gallego, Beatriz, Mateos Egido, Elena, García Reina, Lourdes, Santos Morín, Leonor, Díez Del Pino, Alicia

Publikováno v: Farmacia Hospitalaria, Volume: 40, Issue: 5, Pages: 447-448, Published: OCT 2016

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______624::791a6e4a89f67031b92edba5d340066d
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1130-63432016000500010&lng=en&tlng=en